$0.89
3.86% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US31447E1055
Symbol
FEMY

Femasys Inc Stock price

$0.89
-0.21 19.15% 1M
-0.30 25.27% 6M
-0.21 19.15% YTD
-0.15 14.50% 1Y
-11.11 92.59% 5Y
-11.11 92.59% 10Y
-11.11 92.59% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.04 3.86%
ISIN
US31447E1055
Symbol
FEMY
Sector

Key metrics

Market capitalization $26.97m
Enterprise Value $28.91m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 17.00
P/S ratio (TTM) P/S ratio 15.86
P/B ratio (TTM) P/B ratio 12.55
Revenue growth (TTM) Revenue growth 61.90%
Revenue (TTM) Revenue $1.70m
EBIT (operating result TTM) EBIT $-19.78m
Free Cash Flow (TTM) Free Cash Flow $-20.50m
Cash position $3.82m
EPS (TTM) EPS $-0.83
P/E forward negative
P/S forward 4.06
EV/Sales forward 4.35
Short interest 5.06%
Show more

Is Femasys Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Femasys Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

Buy
100%

Financial data from Femasys Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1.70 1.70
62% 62%
100%
- Direct Costs 0.57 0.57
58% 58%
34%
1.13 1.13
64% 64%
66%
- Selling and Administrative Expenses 11 11
44% 44%
658%
- Research and Development Expense 9.41 9.41
26% 26%
554%
-19 -19
34% 34%
-1,145%
- Depreciation and Amortization 0.31 0.31
26% 26%
18%
EBIT (Operating Income) EBIT -20 -20
32% 32%
-1,164%
Net Profit -21 -21
42% 42%
-1,242%

In millions USD.

Don't miss a Thing! We will send you all news about Femasys Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Femasys Inc Stock News

Neutral
GlobeNewsWire
3 days ago
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® -- ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products announces a par...
Neutral
GlobeNewsWire
15 days ago
ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, today announced that it intends to offer and sell shares of its common stock in an underwritten public of...
Neutral
GlobeNewsWire
about one month ago
-- Company delivers on mission to transform women's health with innovative solutions, including FemaSeed ® for first-line infertility treatment and FemBloc ® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health wor...
More Femasys Inc News

Company Profile

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients fallopian tubes, and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. The firm offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.

Head office United States
CEO Kathy Lee-Sepsick
Employees 33
Founded 2004
Website www.femasys.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today